Search results
Results From The WOW.Com Content Network
Rheumatoid arthritis; ... RA affects about 24.5 million people as of 2015. [10] ... with cigarette smoking as the most clearly defined risk factor.
Smoking-related deaths in firsthand and secondhand smokers in the US between 2005 and 2009 (no data available for secondhand smokers with COPD deaths [7]) The morbidity of cigarette smoking is nearly 50% with 7 million first-hand smokers and 1.2 millions second hand smokers killed each year. [8]
ICD-10 is the 10th revision of the International Classification of Diseases (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. [1]
Smoker melanosis in a patient consuming 2 packs of cigarette per day. Smoking or the use of nicotine-containing drugs is the cause to Smoker's melanosis. [10] [11] Tar-components (benzopyrenes) are also known to stimulate melanocytes to melanin production, and other unknown toxic agents in tobacco may also be the cause.
Smoker's face describes the characteristic changes that happen to the faces of many people who smoke tobacco products. [1] [2] Smoking causes damage to the skin by depleting the skin of oxygen and nutrients. [3] The general appearance is of accelerated ageing of the face, with a characteristic pattern of facial wrinkling and sallow coloration.
The ICD-10 Clinical Modification (ICD-10-CM) is a set of diagnosis codes used in the United States of America. [1] It was developed by a component of the U.S. Department of Health and Human services, [ 2 ] as an adaption of the ICD-10 with authorization from the World Health Organization .
For premium support please call: 800-290-4726 more ways to reach us
Cigarette smoking is now established as a major risk factor for both incidence and severity of rheumatoid arthritis. This may relate to abnormal citrullination of proteins, since the effects of smoking correlate with the presence of antibodies to citrullinated peptides .